{"id":"NCT01389102","sponsor":"Lumara Health, Inc.","briefTitle":"Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms","officialTitle":"A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Estradiol Metered-Dose Transdermal Spray (MDTS) in the Treatment of Vasomotor Symptoms in Postmenopausal Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2006-11","completion":"2006-11","firstPosted":"2011-07-07","resultsPosted":"2012-06-11","lastUpdate":"2012-06-11"},"enrollment":454,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hot Flashes"],"interventions":[{"type":"DRUG","name":"Estradiol transdermal one 90 μL spray","otherNames":[]},{"type":"DRUG","name":"Estradiol transdermal spray, two 90 μL sprays","otherNames":[]},{"type":"DRUG","name":"Estradiol transdermal three 90 μL sprays","otherNames":[]},{"type":"DRUG","name":"Placebo transdermal two 90 μL sprays","otherNames":[]},{"type":"DRUG","name":"Placebo transdermal three 90 μL sprays","otherNames":[]},{"type":"DRUG","name":"Placebo transdermal one 90 μL spray","otherNames":[]}],"arms":[{"label":"Placebo transdermal three 90 μL sprays","type":"PLACEBO_COMPARATOR"},{"label":"Placebo transdermal two 90 μL sprays","type":"PLACEBO_COMPARATOR"},{"label":"Placebo transdermal one 90 μL spray","type":"PLACEBO_COMPARATOR"},{"label":"Estradiol transdermal three 90 μL sprays","type":"ACTIVE_COMPARATOR"},{"label":"Estradiol transdermal two 90 μL sprays","type":"ACTIVE_COMPARATOR"},{"label":"Estradiol transdermal one 90 μL spray","type":"ACTIVE_COMPARATOR"}],"summary":"Estradiol treatment is effective at reducing vasomotor symptoms (eg hot flushes) in postmenopausal women. This study will evaluate the safety and efficacy of Evamist.","primaryOutcome":{"measure":"Mean Change in the Number of Moderate to Severe Vasomotor Symptoms Per Day","timeFrame":"baseline to week 12","effectByArm":[{"arm":"Placebo Transdermal Three 90 μL Sprays","deltaMin":-5.32,"sd":6.3},{"arm":"Placebo Transdermal Two 90 μL Sprays","deltaMin":-6.19,"sd":5.77},{"arm":"Placebo Transdermal One 90 μL Spray","deltaMin":-4.76,"sd":5.84},{"arm":"Estradiol Transdermal Three 90 μL Sprays","deltaMin":-8.44,"sd":4.5},{"arm":"Estradiol Transdermal Two 90 μL Sprays","deltaMin":-8.66,"sd":6.65},{"arm":"Estradiol Transdermal One 90 μL Spray","deltaMin":-8.1,"sd":4.02}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG004","p":"0.0099"},{"comp":"OG005","p":"0.0004"}]},"eligibility":{"minAge":"35 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":43,"countries":["United States"]},"refs":{"pmids":["18515518"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":75},"commonTop":["Headache","Breast Tenderness","Nausea","Nasopharyngitis","Back pain"]}}